Guidelines for the management of Helicobacter pylori infection in Japan：2009 revised edition.
Helicobacter. 15: 1-20. 2010. 2.
The influence of hepatitis B DNA level and antiviral therapy on recurrence after initial curative treatment in patients with hepatocellular carcinoma.
J Gastroenterol. 44: 991-999. 2009. 9.
Efficacy and resistance of entecavir following 3 years of treatment of Japanese patients with lamivudine-refractory chronic hepatitis B.
Hepatol Int. 4: 414-422. 2010. 2.
Peroral cholangioscopy for the diagnosis of bile duct carcinoma with extensive intraepithelial spread.
Endoscopy. 41: 959-964. 2009. 11.
A prospective randomized controlled multicenter trial of duodenoscopes with 5° and 15° backward-oblique angle using wire-guided cannulation: effects on selective cannulation of the common bile duct in endoscopic retrograde cholangiopancreatography.
J Gastroenterol. 44: 1140-1146. 2009. 11.
Successful voriconazole treatment of invasive pulmonary aspergillosis in a patient with acute biphenotypic leukemia.
Acta Medica Okayama. 63: 213-216. 2009. 8.
Diffuse large B-cell lymphoma with massive portal vein tumor thrombosis in a patient with alcoholic cirrhosis: A case report and literature review.
Intern Med. 48: 805-808. 2009. 5.
Sunitinib-resistant gastrointestinal stromal tumors harbor cis-mutations in the activation loop of the KIT gene.
Int J Clin Oncol. 14: 143-149. 2009. 4.
Involvement of tazarotene-induced gene 1 （TIG1） in proliferation and differentiation of human adipose tissue-derived mesenchymal stem cells.
Cell Proliferation. 133: 309-316. 2009. 6.
Effects of preoperative administration of omeprazole on bleeding after endoscopic submucosal dissection: a prospective randomized controlled trial.
Endoscopy. 41: 299-303. 2009. 4.
Immediate acid-suppressing effects of ranitidine hydrochloride and rabeprazole sodium following initial administration and reintroduction: A randomized, cross-over study using wireless pH monitoring capsules.
J Gastroenterol Hepatol. 24: 639-645. 2009. 4.
Preliminary trial of rebamipide for prevention of low-dose aspirin-induced gastric injury in healthy subjects: a randomized, double-blind, placebo-controlled, cross-over study.
J Clin Biochem Nutr. 45: 248-253. 2009. 8.
Fascin is involved in tumor necrosis factor-alpha-dependent production of MMP9 in cholangiocarcinoma.
Lab Invest. 89: 1261-1274. 2009. 11.
Incidence and risk of postherpetic neuralgia after varicella zoster virus infection in hematopoietic cell transplantation recipients: Hokkaido Hematology Study Group.
Biol Blood Marrow Transplant. 15: 724-729. 2009. 6.
Short-term and long-term outcome of endoluminal gastroplication for the treatment of GERD: the first multicenter trial in Japan.
J Gastroenterol. 44: 675-684. 2009. 7.
Endoscopic ultrasonographic evaluation of hemodyna-mics related to variceal relapse in esophageal variceal patients.
Hepatology Research. 39: 126-133. 2009. 4.
Evaluation of therapeutic effects on rectal varices using percutaneous color Doppler ultrasonography.
Hepatol Res. 39: 694-699. 2009. 7.
Diagnosis of gastric varices and evaluation of the effectiveness of treatment using transabdominal color Doppler ultrasonography.
J Ultrasound Med. 28: 1125-1131. 2009. 9.
Regimen-related mucosal injury of the gut increased the incidence of CMV disease after allogeneic bone marrow transplantation.
Biol Blood Marrow Transplant. 15: 679-685. 2009. 6.
Long-term outcome after endoscopic resection in patients with hypopharyngeal carcinoma invading the subepithelium：a case series.
Endoscopy. 41: 374-376. 2009. 4.
Low-grade dysplasia component in early invasive squamous cell carcinoma of the esophagus.
J Gastroenterol Hepatol. 25: 314-318. 2010. 2.
Rikkunshito ameliorates the aging-associated decrease in ghrelin receptor reactivity via phosphodiesterase III inhibition.
Endocrinology. 151: 244-252. 2010. 1.
Increased number of CD16＋CD56dim NK cells in peripheral blood mononuclear cells after allogeneic cord blood transplantation.
Human Immunol . 70: 701-705. 2009. 9.
Serum macrophage migration inhibitory factor （MIF） levels after allogeneic hematopoietic stem cell transplantation.
Int J Lab Hemato. 31: 161-168. 2009. 4.
Serum soluble tumor necrosis factor-related apoptosis-inducing ligand level after allogeneic hematopoietic stem cell transplantation.
Leuk Lymphoma. 50: 844-847. 2009. 5.
Analysis of reactivation of hepatitis B virus in the treatment of B cell non-Hodgkin’s lymphoma in Hokkaido.
Ann Hematol. 88: 375-377. 2009. 4.
Changes in hepatitis C virus antibody titer and viral RNA load in non-Hodgkins lymphoma patients after rituximab chemotherapy.
Int J Lab Hemato. 31: 468-470. 2009. 8.
Modified-irinotecan/fluorouracil/levoleucovorin therapy as ambulatory treatment for metastatic colorectal cancer: results of phase I and II studies.
Clin Drug Investig. 30: 243-249. 2010. 2.